Optimal timing for hospice-shared care initiation in terminal cancer patients

2021 ◽  
Author(s):  
Yan-Mei Dai ◽  
Ya-Ting Huang ◽  
Min-Yu Lai ◽  
Hsueh-Erh Liu ◽  
Chih-Chung Shiao
Keyword(s):  
Cancer Patients ◽  
Shared Care ◽  
Optimal Timing ◽  
Terminal Cancer ◽  
Terminal Cancer Patients

scholarly journals Optimal Timing for Hospice-shared Care in Terminal Cancer Patients

2020 ◽  
Author(s):  
Yan-Mei Dai ◽  
Ya-Ting Huang ◽  
Min-Yu Lai ◽  
Hsueh-Erh Liu ◽  
Chih-Chung Shiao
Keyword(s):  
Cancer Patients ◽  
Population Based ◽  
Shared Care ◽  
Optimal Timing ◽  
Terminal Cancer ◽  
Medical Expenses ◽  
Beneficial Effects ◽  
Matching Process ◽  
Terminal Cancer Patients ◽  
Generalized Linear Mixed Effects

Abstract The optimal timing for initiating palliative care in cancer patients varied widely. This retrospective population-based study aimed to determine the optimal initiation timing of hospice-shared care (HSC), which maximizes the beneficial effects of quality of care (QOC) and medical expenses among terminal cancer patients. We extracted cancer patients who were in their last year of lives during 1 January 2010 to 31 December 2013 from a nationwide database. After the selection and matching process, 1,714 patients (67.7±13.2 years, 62.7% male) were enrolled and categorized into the HSC group and usual care (UC) group (n=857 in each group). By suing the generalized linear mixed-effects model for comparisons between groups, we found that the HSC groups showed generally better QOC in the four indices (with emergency room visit, hospitalization, intensive care unit admission, and receiving chemotherapy) than the UC group in those who initiated HSC 8-60 days before death. The HSC group also had significantly lower medical expenses than the UC group in those who initiated HSC 15-90 days before death. In conclusion, HSC initiation before the last eight days and 15 days of lives were found to effectively improve QOC and save medical expenses, respectively, among patients with terminal cancer.

Changes in the palliative performance scale may be as important as the initial palliative performance scale for predicting survival in terminal cancer patients

2021 ◽  
pp. 1-5
Author(s):  
Guk Jin Lee ◽  
Ji Hyun Gwak ◽  
Myoung Sim Kim ◽  
Mi Yeong Lee ◽  
Seo Ree Kim ◽  
...  
Keyword(s):  
Cancer Patients ◽  
Gastrointestinal Cancer ◽  
Poor Prognosis ◽  
Accurate Estimation ◽  
Terminal Cancer ◽  
Hospice Patients ◽  
Terminal Cancer Patients ◽  
Group A ◽  
Group B ◽  
Performance Scale

Abstract Objective The accurate estimation of expected survival in terminal cancer patients is important. The palliative performance scale (PPS) is an important factor in predicting survival of hospice patients. The purpose of this study was to examine how initial status of PPS and changes in PPS affect the survival of hospice patients in Korea. Method We retrospectively examined 315 patients who were admitted to our hospice unit between January 2017 and December 2018. The patients were divided based on the PPS of ≥50% (group A) and ≤40% (group B). We performed survival analysis for factors associated with the length of survival (LOS) in group A. Based on the hospice team's weekly evaluation of PPS, we examined the effect of initial levels and changes in group A on the prognosis of patients who survived for 2 weeks or more. Results At the time of admission to hospice, 265 (84.1%) patients were PPS ≥50%, and 50 (15.9%) were PPS ≤40%. The median LOS of PPS ≥50% and PPS ≤40% were 15 (2–158 days) and 9 (2–43 days), respectively. Male, gastrointestinal cancer, and lower initial PPS all predicted poor prognosis in group A. Male, gastrointestinal cancer, and a PPS change of 10% or greater, compared with initial status 1 week and 2 weeks of hospitalization, were all predictors of poor prognosis in group A patients who survived for 2 weeks or longer. Significance of results Our research demonstrates the significance of PPS change at 1 week and 2 weeks, suggesting the importance of evaluating not only initial PPS but also change in PPS.

scholarly journals Intravenous ATP infusions can be safely administered in the home setting: a study in pre-terminal cancer patients

2007 ◽  
Vol 25 (6) ◽  
pp. 571-579 ◽  
Author(s):  
Sandra Beijer ◽  
Eric A. R. Gielisse ◽  
Pierre S. Hupperets ◽  
Ben E. E. M. van den Borne ◽  
Marieke van den Beuken-van Everdingen ◽  
...  
Keyword(s):  
Cancer Patients ◽  
Terminal Cancer ◽  
Home Setting ◽  
Terminal Cancer Patients

Methylprednisolone as palliative therapy for female terminal cancer patients

1989 ◽  
Vol 25 (12) ◽  
pp. 1823-1829 ◽  
Author(s):  
Craig A. Metz ◽  
T. Popiela ◽  
Renato Lucchi ◽  
Fulvio Giongo
Keyword(s):  
Cancer Patients ◽  
Palliative Therapy ◽  
Terminal Cancer ◽  
Terminal Cancer Patients
Sign in / Sign up

Export Citation Format

Share Document